{"id":3177,"date":"2021-05-25T23:30:20","date_gmt":"2021-05-25T23:30:20","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=3177"},"modified":"2023-08-29T17:49:38","modified_gmt":"2023-08-29T17:49:38","slug":"creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=3177","title":{"rendered":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565"},"content":{"rendered":"<p><a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=CPH&amp;lang=cn\">Creso Pharma (ASX: CPH)<\/a>\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002<\/p>\n<p>\u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u4e24\u5bb6\u516c\u53f8\u5c06\u8fdb\u884c\u6280\u672f\u8bc4\u4f30\uff0c\u4ee5\u63a8\u8fdb\u4e00\u9879\u76ee\u524d\u6b63\u5728\u5f00\u53d1\u7684\u690d\u7269\u6027\u836f\u7269\u5728\u7f8e\u56fd\u7684\u5e02\u573a\u5f00\u53d1\u8ba1\u5212\u3002<\/p>\n<p>\u8bc4\u4f30\u5c06\u5305\u62ec\u4e34\u5e8a\u6307\u5f81\u54a8\u8be2;\u62df\u8bae\u6210\u5206\u7684\u89c4\u7ba1\u72b6\u51b5;\u91c7\u8d2d\u3001\u5236\u9020\u548c\u914d\u65b9;\u7f16\u5236\u652f\u6301\u6027\u6570\u636e;\u4ee5\u53ca\u77e5\u8bc6\u4ea7\u6743\u65b9\u9762\u7684\u8003\u8651\u3002<\/p>\n<h2>\u91cd\u8981\u7684\u7b2c\u4e00\u6b65<\/h2>\n<p>Halucenex\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8868\u793a\uff0c\u8be5\u534f\u8bae\u6807\u5fd7\u7740\u8fd9\u5bb6\u52a0\u62ff\u5927\u516c\u53f8\u5411\u7f8e\u56fd\u5e02\u573a\u8fc8\u51fa\u4e86\u91cd\u8981\u7684\u7b2c\u4e00\u6b65\u3002<\/p>\n<p>\u4ed6\u8868\u793a:\u201c\u7f8e\u56fd\u5c06\u6210\u4e3a\u81f4\u5e7b\u5242\u66ff\u4ee3\u7597\u6cd5\u6700\u91cd\u8981\u3001\u6700\u6709\u5229\u53ef\u56fe\u7684\u5e02\u573a\uff0c\u56e0\u6b64(\u6211\u4eec)\u73b0\u5728\u5c31\u5f00\u59cb\u8ba1\u5212\u8fdb\u5165\u5e02\u573a\u52bf\u5728\u5fc5\u884c\u3002\u201d<\/p>\n<p>\u201c\u9274\u4e8eHeteroGeneity\u5728\u65b0\u836f\u3001\u533b\u7597\u8bbe\u5907\u548c\u6cbb\u7597\u65b9\u9762\u83b7\u5f97FDA\u6279\u51c6\u7684\u8bb0\u5f55\uff0c\u6211\u4eec\u76f8\u4fe1HeteroGeneity\u662f\u5e2e\u52a9\u6211\u4eec\u524d\u8fdb\u7684\u5408\u9002\u5408\u4f5c\u4f19\u4f34\uff0c\u6211\u4eec\u671f\u5f85\u4e0e\u8be5\u96c6\u56e2\u5408\u4f5c\uff0c\u786e\u5b9a\u8fd9\u4e2a\u65b0\u5e02\u573a\u7684\u5373\u65f6\u8981\u6c42\u3002\u201d<\/p>\n<p>Fleming\u8868\u793a\uff0cHeteroGeneity\u5728\u672c\u5730\u7684\u7ecf\u9a8c\u5c06\u6709\u52a9\u4e8e\u83b7\u5f97\u76d1\u7ba1\u673a\u6784\u7684\u6279\u51c6\uff0c\u5e76\u63a8\u8fdb\u4e0e\u5927\u578b\u5236\u836f\u516c\u53f8\u7684\u8bb8\u53ef\u8bc1\u8c08\u5224\u3002<\/p>\n<h2>\u6218\u7565\u5efa\u8bae<\/h2>\n<p>HeteroGeneity\u4e3a\u5bfb\u6c42\u5728\u7f8e\u56fd\u548c\u52a0\u62ff\u5927\u5e02\u573a\u5546\u4e1a\u5316\u65b0\u836f\u3001\u751f\u7269\u5236\u5242\u548c\u533b\u7597\u8bbe\u5907\u7684\u5ba2\u6237\u63d0\u4f9b\u6218\u7565\u548c\u6280\u672f\u63f4\u52a9\u3002<\/p>\n<p>\u8be5\u5c0f\u7ec4\u4e13\u95e8\u7814\u7a76\u590d\u6742\u3001\u5f02\u8d28\u6df7\u5408\u7269\u7684\u76d1\u7ba1\u3001\u653f\u7b56\u548c\u79d1\u5b66\uff0c\u5e76\u9488\u5bf9\u4f20\u7edf\u533b\u5b66\u5b9e\u8df5\u4e2d\u7684\u4ea7\u54c1\u4ee5\u53ca\u5176\u4ed6\u81ea\u7136\u6216\u5386\u53f2\u4e0a\u590d\u6742\u7684\u4ea7\u54c1\u7684\u65b0\u7528\u9014\u9886\u57df\u8fdb\u884c\u7814\u7a76\u3002<\/p>\n<p>HeteroGeneity\u5c06\u81ea\u5df1\u4f5c\u4e3a\u5ba2\u6237\u516c\u53f8\u7684\u201c\u865a\u62df\u7814\u53d1\u201d\u90e8\u95e8\u8fdb\u884c\u8425\u9500\uff0c\u6c47\u96c6\u4e86\u6765\u81ea\u690d\u7269\u5b66\u3001\u836f\u7406\u5b66\u3001\u751f\u836f\u5b66\u3001\u6bd2\u7406\u5b66\u3001\u5fae\u751f\u7269\u5b66\u3001\u5316\u5b66\u548c\u5408\u89c4\u7b49\u9886\u57df\u7684\u4e13\u5bb6\u3002<\/p>\n<p>\u5b83\u5e2e\u52a9\u8bb8\u591a\u516c\u53f8\u901a\u8fc7\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u83b7\u5f97\u65b0\u836f\u6279\u51c6\u3002<\/p>\n<h2>\u7f8e\u56fd\u7684\u5e02\u573a\u4ef7\u503c<\/h2>\n<p>\u8ff7\u5e7b\u5242\u8f85\u52a9\u7597\u6cd5\u662f\u4e00\u79cd\u76f8\u5bf9\u8f83\u65b0\u7684\u66ff\u4ee3\u6cbb\u7597\u9014\u5f84\uff0c\u5728\u533b\u7597\u73af\u5883\u4e2d\u4f7f\u7528\u65f6\u5df2\u663e\u793a\u51fa\u76f8\u5f53\u5927\u7684\u524d\u666f\u3002<\/p>\n<p>\u52302027\u5e74\uff0c\u7f8e\u56fd\u8ff7\u5e7b\u6cbb\u7597\u836f\u7269\u5e02\u573a\u7684\u603b\u4ef7\u503c\u9884\u8ba1\u5c06\u8fbe\u523086.2\u4ebf\u6fb3\u5143\u3002<\/p>\n<p>Fleming\u76f8\u4fe1\uff0c<a href=\"http:\/\/smallcaps-production.test\/creso-pharmas-acquisition-target-halucenex-prepares-ptsd-trials\/?lang=cn\">Halucenex\u5373\u5c06\u8fdb\u884c\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5c06\u5bf9\u88f8\u5934\u8349\u7d20<\/a>(psilocybin\uff0c\u795e\u5947\u8611\u83c7\u7684\u6d3b\u6027\u6210\u5206)\u5728\u8010\u6cbb\u7597\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(ptsd)\u60a3\u8005\u4e2d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u8fdb\u884c\u7814\u7a76\uff0c\u8fd9\u5c06\u4f7f\u8be5\u516c\u53f8\u83b7\u5f97\u201c\u76f8\u5f53\u5927\u7684\u7ade\u4e89\u4f18\u52bf\u201d\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002 \u6839\u636e\u534f\u8bae\u6761\u6b3e\uff0c\u4e24\u5bb6\u516c\u53f8\u5c06\u8fdb\u884c\u6280\u672f\u8bc4\u4f30\uff0c\u4ee5\u63a8\u8fdb\u4e00\u9879\u76ee\u524d\u6b63\u5728\u5f00\u53d1\u7684\u690d\u7269\u6027\u836f\u7269\u5728\u7f8e\u56fd\u7684\u5e02\u573a\u5f00\u53d1\u8ba1\u5212\u3002 \u8bc4\u4f30\u5c06\u5305\u62ec\u4e34\u5e8a\u6307\u5f81\u54a8\u8be2;\u62df\u8bae\u6210\u5206\u7684\u89c4\u7ba1\u72b6\u51b5;\u91c7\u8d2d\u3001\u5236\u9020\u548c\u914d\u65b9;\u7f16\u5236\u652f\u6301\u6027\u6570\u636e;\u4ee5\u53ca\u77e5\u8bc6\u4ea7\u6743\u65b9\u9762\u7684\u8003\u8651\u3002 \u91cd\u8981\u7684\u7b2c\u4e00\u6b65 Halucenex\u9996\u5e2d\u6267\u884c\u5b98Bill Fleming\u8868\u793a\uff0c\u8be5\u534f\u8bae\u6807\u5fd7\u7740\u8fd9\u5bb6\u52a0\u62ff\u5927\u516c\u53f8\u5411\u7f8e\u56fd\u5e02\u573a\u8fc8\u51fa\u4e86\u91cd\u8981\u7684\u7b2c\u4e00\u6b65\u3002 \u4ed6\u8868\u793a:\u201c\u7f8e\u56fd\u5c06\u6210\u4e3a\u81f4\u5e7b\u5242\u66ff\u4ee3\u7597\u6cd5\u6700\u91cd\u8981\u3001\u6700\u6709\u5229\u53ef\u56fe\u7684\u5e02\u573a\uff0c\u56e0\u6b64(\u6211\u4eec)\u73b0\u5728\u5c31\u5f00\u59cb\u8ba1\u5212\u8fdb\u5165\u5e02\u573a\u52bf\u5728\u5fc5\u884c\u3002\u201d \u201c\u9274\u4e8eHeteroGeneity\u5728\u65b0\u836f\u3001\u533b\u7597\u8bbe\u5907\u548c\u6cbb\u7597\u65b9\u9762\u83b7\u5f97FDA\u6279\u51c6\u7684\u8bb0\u5f55\uff0c\u6211\u4eec\u76f8\u4fe1HeteroGeneity\u662f\u5e2e\u52a9\u6211\u4eec\u524d\u8fdb\u7684\u5408\u9002\u5408\u4f5c\u4f19\u4f34\uff0c\u6211\u4eec\u671f\u5f85\u4e0e\u8be5\u96c6\u56e2\u5408\u4f5c\uff0c\u786e\u5b9a\u8fd9\u4e2a\u65b0\u5e02\u573a\u7684\u5373\u65f6\u8981\u6c42\u3002\u201d Fleming\u8868\u793a\uff0cHeteroGeneity\u5728\u672c\u5730\u7684\u7ecf\u9a8c\u5c06\u6709\u52a9\u4e8e\u83b7\u5f97\u76d1\u7ba1\u673a\u6784\u7684\u6279\u51c6\uff0c\u5e76\u63a8\u8fdb\u4e0e\u5927\u578b\u5236\u836f\u516c\u53f8\u7684\u8bb8\u53ef\u8bc1\u8c08\u5224\u3002 \u6218\u7565\u5efa\u8bae HeteroGeneity\u4e3a\u5bfb\u6c42\u5728\u7f8e\u56fd\u548c\u52a0\u62ff\u5927\u5e02\u573a\u5546\u4e1a\u5316\u65b0\u836f\u3001\u751f\u7269\u5236\u5242\u548c\u533b\u7597\u8bbe\u5907\u7684\u5ba2\u6237\u63d0\u4f9b\u6218\u7565\u548c\u6280\u672f\u63f4\u52a9\u3002 \u8be5\u5c0f\u7ec4\u4e13\u95e8\u7814\u7a76\u590d\u6742\u3001\u5f02\u8d28\u6df7\u5408\u7269\u7684\u76d1\u7ba1\u3001\u653f\u7b56\u548c\u79d1\u5b66\uff0c\u5e76\u9488\u5bf9\u4f20\u7edf\u533b\u5b66\u5b9e\u8df5\u4e2d\u7684\u4ea7\u54c1\u4ee5\u53ca\u5176\u4ed6\u81ea\u7136\u6216\u5386\u53f2\u4e0a\u590d\u6742\u7684\u4ea7\u54c1\u7684\u65b0\u7528\u9014\u9886\u57df\u8fdb\u884c\u7814\u7a76\u3002 HeteroGeneity\u5c06\u81ea\u5df1\u4f5c\u4e3a\u5ba2\u6237\u516c\u53f8\u7684\u201c\u865a\u62df\u7814\u53d1\u201d\u90e8\u95e8\u8fdb\u884c\u8425\u9500\uff0c\u6c47\u96c6\u4e86\u6765\u81ea\u690d\u7269\u5b66\u3001\u836f\u7406\u5b66\u3001\u751f\u836f\u5b66\u3001\u6bd2\u7406\u5b66\u3001\u5fae\u751f\u7269\u5b66\u3001\u5316\u5b66\u548c\u5408\u89c4\u7b49\u9886\u57df\u7684\u4e13\u5bb6\u3002 \u5b83\u5e2e\u52a9\u8bb8\u591a\u516c\u53f8\u901a\u8fc7\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u83b7\u5f97\u65b0\u836f\u6279\u51c6\u3002 \u7f8e\u56fd\u7684\u5e02\u573a\u4ef7\u503c \u8ff7\u5e7b\u5242\u8f85\u52a9\u7597\u6cd5\u662f\u4e00\u79cd\u76f8\u5bf9\u8f83\u65b0\u7684\u66ff\u4ee3\u6cbb\u7597\u9014\u5f84\uff0c\u5728\u533b\u7597\u73af\u5883\u4e2d\u4f7f\u7528\u65f6\u5df2\u663e\u793a\u51fa\u76f8\u5f53\u5927\u7684\u524d\u666f\u3002 \u52302027\u5e74\uff0c\u7f8e\u56fd\u8ff7\u5e7b\u6cbb\u7597\u836f\u7269\u5e02\u573a\u7684\u603b\u4ef7\u503c\u9884\u8ba1\u5c06\u8fbe\u523086.2\u4ebf\u6fb3\u5143\u3002 Fleming\u76f8\u4fe1\uff0cHalucenex\u5373\u5c06\u8fdb\u884c\u7684\u4e8c\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5c06\u5bf9\u88f8\u5934\u8349\u7d20(psilocybin\uff0c\u795e\u5947\u8611\u83c7\u7684\u6d3b\u6027\u6210\u5206)\u5728\u8010\u6cbb\u7597\u521b\u4f24\u540e\u5e94\u6fc0\u969c\u788d(ptsd)\u60a3\u8005\u4e2d\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u8fdb\u884c\u7814\u7a76\uff0c\u8fd9\u5c06\u4f7f\u8be5\u516c\u53f8\u83b7\u5f97\u201c\u76f8\u5f53\u5927\u7684\u7ade\u4e89\u4f18\u52bf\u201d\u3002<\/p>\n","protected":false},"author":4,"featured_media":11847,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[721],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565<\/title>\n<meta name=\"description\" content=\"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565\" \/>\n<meta property=\"og:description\" content=\"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-25T23:30:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:49:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Creso-Pharma-Canadian-Halucenex-US-market-entry-strategy-ASX-CPH-North-America.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565\" \/>\n<meta name=\"twitter:description\" content=\"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/\",\"name\":\"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-05-25T23:30:20+00:00\",\"dateModified\":\"2023-08-29T17:49:38+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565","description":"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565","og_description":"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/","og_site_name":"smallcapsCN","article_published_time":"2021-05-25T23:30:20+00:00","article_modified_time":"2023-08-29T17:49:38+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Creso-Pharma-Canadian-Halucenex-US-market-entry-strategy-ASX-CPH-North-America.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565","twitter_description":"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/","url":"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/","name":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-05-25T23:30:20+00:00","dateModified":"2023-08-29T17:49:38+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"Creso Pharma (ASX: CPH)\u5373\u5c06\u6210\u4e3a\u5b50\u516c\u53f8\u7684Halucenex Life Sciences Inc\u4e0e\u7f8e\u56fd\u79d1\u5b66\u54a8\u8be2\u516c\u53f8HeteroGeneity LLC\u7b7e\u7f72\u4e86\u4e00\u9879\u534f\u8bae\uff0c\u4ee5\u63a8\u8fdb\u5176\u4e00\u7cfb\u5217\u690d\u7269\u6027\u88f8\u76d6\u83c7\u7d20\u4ea7\u54c1\u548c\u5316\u5408\u7269\u7684\u7f8e\u56fd\u5e02\u573a\u8fdb\u5165\u6218\u7565\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/creso-pharma-canadian-subsidiary-halucenex-us-market-entry-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Creso Pharma\u7684\u52a0\u62ff\u5927\u5b50\u516c\u53f8Halucenex\u5f00\u59cb\u8fdb\u5165\u7f8e\u56fd\u5e02\u573a\u7684\u6218\u7565"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3177"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3177"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3177\/revisions"}],"predecessor-version":[{"id":11846,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3177\/revisions\/11846"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/11847"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}